Description

FARROWSURE® PLUS B is a liquid preparation of porcine parvovirus grown on an established porcine cell line, a serum-free, clarified E. rhusiopathiae culture, and whole cell cultures of the 6 Leptospira serovars identified above. The antigens have been chemically inactivated and adjuvanted with 2 adjuvants, including Amphigen®, to enhance the immune response.

Approved Uses

Vaccination of healthy breeding swine as an aid in preventing reproductive failure caused by porcine parvovirus (PPV), erysipelas caused by Erysipelothrix rhusiopathiae, and leptospirosis caused by Leptospira bratislava, L. canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae and L. pomona. A 26-week duration of immunity following vaccination has been demonstrated against erysipelas

Key Features

- FARROWSURE PLUS B is the only vaccine with a labeled duration of immunity against erysipelas of 26 weeks.
- The duration of immunity of 26 weeks provides for litter-to-litter erysipelas protection.
- The only reproductive vaccines that contain Amphigen.
- FARROWSURE PLUS B optimizes breeding herd performance by controlling erysipelas, parvovirus and leptospirosis with minimum vaccination stress.
- By controlling these diseases, farrowing rates and number of pigs born alive can be improved, and non-productive sow days can be reduced.
- FARROWSURE PLUS B offers proven protection against porcine parvovirus, erysipelas, and six strains of leptospira, including L.
Packaging

50-dose and 100-dose vials

**This product has been discontinued.  It has been replaced with FarrowSure Gold B which is in stock.